These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 9808589)

  • 21. Additional monoclonal antibody (mAB) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation.
    Tomita Y; Sachs DH; Khan A; Sykes M
    Transplantation; 1996 Feb; 61(3):469-77. PubMed ID: 8610363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Keratinocyte growth factor administered before conditioning ameliorates graft-versus-host disease after allogeneic bone marrow transplantation in mice.
    Panoskaltsis-Mortari A; Lacey DL; Vallera DA; Blazar BR
    Blood; 1998 Nov; 92(10):3960-7. PubMed ID: 9808590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term immune reconstitution and outcome after HLA-nonidentical T-cell-depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients.
    Haddad E; Landais P; Friedrich W; Gerritsen B; Cavazzana-Calvo M; Morgan G; Bertrand Y; Fasth A; Porta F; Cant A; Espanol T; Müller S; Veys P; Vossen J; Fischer A
    Blood; 1998 May; 91(10):3646-53. PubMed ID: 9573000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maternal microchimerism and cell-mediated immune-modulation enhance engraftment following semi-allogenic intrauterine transplantation.
    Kandasamy K; Tan LG; B Johana N; Tan YW; Foo W; Yeo JSL; Ravikumar V; Ginhoux F; Choolani M; Chan JKY; Mattar CNZ
    FASEB J; 2021 Mar; 35(3):e21413. PubMed ID: 33570785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of pretransplant conditioning and donor T cells on chimerism, graft-versus-host disease, graft-versus-leukemia reactivity, and tolerance after bone marrow transplantation.
    Truitt RL; Atasoylu AA
    Blood; 1991 Jun; 77(11):2515-23. PubMed ID: 2039833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of the additional injection of host-type bone marrow on the immune tolerance of minor antigen-mismatched chimeras: possible involvement of double-negative (natural killer) T cells.
    Sefrioui H; Billiau AD; Overbergh L; Rutgeerts O; Waer M
    Transplantation; 1999 Nov; 68(10):1560-7. PubMed ID: 10589955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of tolerance in nondefective mice after in utero transplantation of major histocompatibility complex-mismatched fetal hematopoietic stem cells.
    Carrier E; Lee TH; Busch MP; Cowan MJ
    Blood; 1995 Dec; 86(12):4681-90. PubMed ID: 8541562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease.
    Alpdogan O; Schmaltz C; Muriglan SJ; Kappel BJ; Perales MA; Rotolo JA; Halm JA; Rich BE; van den Brink MR
    Blood; 2001 Oct; 98(7):2256-65. PubMed ID: 11568014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Donor gamma delta T lymphocytes promote allogeneic engraftment across the major histocompatibility barrier in mice.
    Drobyski WR; Majewski D
    Blood; 1997 Feb; 89(3):1100-9. PubMed ID: 9028343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment.
    Drobyski WR; Majewski D; Ozker K; Hanson G
    J Immunol; 1998 Sep; 161(5):2610-9. PubMed ID: 9725263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD6+ donor marrow T-cell depletion as the sole form of graft-versus-host disease prophylaxis in patients undergoing allogeneic bone marrow transplant from unrelated donors.
    Soiffer RJ; Weller E; Alyea EP; Mauch P; Webb IL; Fisher DC; Freedman AS; Schlossman RL; Gribben J; Lee S; Anderson KC; Marcus K; Stone RM; Antin JH; Ritz J
    J Clin Oncol; 2001 Feb; 19(4):1152-9. PubMed ID: 11181681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allogenic fetal liver cells have a distinct competitive engraftment advantage over adult bone marrow cells when infused into fetal as compared with adult severe combined immunodeficient recipients.
    Taylor PA; McElmurry RT; Lees CJ; Harrison DE; Blazar BR
    Blood; 2002 Mar; 99(5):1870-2. PubMed ID: 11861310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transplantation of X-linked severe combined immunodeficient dogs with CD34+ bone marrow cells.
    Hartnett BJ; Yao D; Suter SE; Ellinwood NM; Henthorn PS; Moore PE; McSweeney PA; Nash RA; Brown JD; Weinberg KI; Felsburg PJ
    Biol Blood Marrow Transplant; 2002; 8(4):188-97. PubMed ID: 12014808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delayed infusion of immunocompetent donor cells after bone marrow transplantation breaks graft-host tolerance allows for persistent antileukemic reactivity without severe graft-versus-host disease.
    Johnson BD; Truitt RL
    Blood; 1995 Jun; 85(11):3302-12. PubMed ID: 7756664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased risk of lethal graft-versus-host disease-like syndrome after transplantation into NOD/SCID mice of human mobilized peripheral blood stem cells, as compared to bone marrow or cord blood.
    Gorin NC; Piantadosi S; Stull M; Bonte H; Wingard JR; Civin C
    J Hematother Stem Cell Res; 2002 Apr; 11(2):277-92. PubMed ID: 11983099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of the spleen on compartmental levels and distribution of donor progenitor cells after syngeneic and allogeneic bone marrow transplants.
    Shatry AM; Jones M; Levy RB
    Stem Cells Dev; 2004 Feb; 13(1):51-62. PubMed ID: 15068693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transplantation of allogeneic bone marrow without graft-versus-host disease using total lymphoid irradiation.
    Slavin S; Fuks Z; Kaplan HS; Strober S
    J Exp Med; 1978 Apr; 147(4):963-72. PubMed ID: 25942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chimerism and tolerance: from freemartin cattle and neonatal mice to humans.
    Jankowski RA; Ildstad ST
    Hum Immunol; 1997 Feb; 52(2):155-61. PubMed ID: 9077564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of immature dendritic cells genetically modified to express sTNFR I on graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) in allogeneic bone marrow transplantation mice].
    Wang SH; Li DP; Zhang YJ; Zhang P; Zeng LY; Pan XY; Xu KL; Huang YH
    Zhonghua Xue Ye Xue Za Zhi; 2012 Feb; 33(2):88-93. PubMed ID: 22730654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Achieving alloengraftment without graft-versus-host disease: approaches using mixed allogeneic bone marrow transplantation.
    Sykes M; Sharabi Y; Sachs DH
    Bone Marrow Transplant; 1988 Sep; 3(5):379-86. PubMed ID: 3056545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.